Skip to main content
TipRanks
Go Ultimate75% OFF

JMS Co., Ltd. (7702) AI Stock Analysis

0 Followers
JP:7702

JMS Co., Ltd.

(TSE/TYO:7702)

Select Model
Rating:52Neutral
Price Target:JPY 470.00▲(9.56% Upside)
Action:reiterated
Date:08/17/26

The score is held down primarily by weak financial performance—profitability has deteriorated into a recent net loss and free cash flow has been volatile and often negative—despite a relatively stable balance sheet. Technicals are a positive offset with the price above key moving averages and constructive momentum indicators. Valuation is only modestly supportive due to a negative P/E, partially balanced by a ~3.66% dividend yield.

Positive Factors
Stable Balance SheetThe equity cushion and moderate debt load provide financial resilience and support ongoing operations. Although leverage has risen, the balance sheet remains sufficiently stable to absorb near-term earnings weakness.
Negative Factors
Revenue ContractionDeclining revenue signals weaker demand, volume, pricing, or market execution and limits operating leverage. If this trend persists, it can make fixed costs harder to absorb and further pressure margins and profitability.

JMS Co., Ltd. (7702) vs. iShares MSCI Japan ETF (EWJ)

-5%0%5%10%15%20%25%JP:7702+2.20%EWJ+15.75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 10.57B
Dividend Yield
3.96%
Average Volume (3M)
35.55K
Price to Earnings (P/E)
-14.9
Beta (1Y)
0.59
Revenue Growth
-3.10%
EPS Growth
-645.01%
Country
Japan
Employees
4,887
Sector
General
Sector Strength
55
Industry
Medical - Instruments & Supplies

JMS Co., Ltd. Business Overview & Revenue Model

Company Description

JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both Ja...

How the Company Makes Money

null

JMS Co., Ltd. Financial Statement Overview

Summary

Financial quality is pressured by weakening profitability and cash generation. The income statement shows a return to net loss (latest year) alongside declining revenue and thinner margins, while cash flow is inconsistent with frequently negative free cash flow (including the latest year). The balance sheet is relatively stable with sizable equity, but leverage has been drifting higher, limiting flexibility if earnings remain soft.

Income Statement

34Negative

Balance Sheet

58Neutral

Cash Flow

38Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue65.43B65.84B69.75B65.29B63.74B58.17B
Gross Profit15.49B15.36B15.93B14.09B14.60B14.27B
EBITDA4.66B4.22B4.79B4.08B4.38B4.59B
Net Income-704.00M-784.00M89.00M-36.00M281.00M826.00M
Balance Sheet
Total Assets82.82B83.07B81.43B84.71B74.41B71.97B
Cash, Cash Equivalents and Short-Term Investments8.78B7.72B5.51B10.31B6.33B6.81B
Total Debt26.15B28.01B24.55B26.92B19.75B18.71B
Total Liabilities41.10B41.27B40.50B43.96B35.70B34.87B
Stockholders Equity41.66B41.73B40.84B40.57B38.53B36.96B
Cash Flow
Free Cash Flow0-892.00M-1.42B498.00M-1.07B1.14B
Operating Cash Flow01.58B1.47B3.14B2.48B4.40B
Investing Cash Flow0-2.25B-3.14B-4.24B-3.69B-3.68B
Financing Cash Flow02.69B-3.19B4.78B525.00M-499.00M

JMS Co., Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price429.00

Price Trends

50DMA444.26Negative
100DMA445.42Negative
200DMA434.41Negative

Market Momentum

MACD-5.00Positive
RSI44.15Neutral
STOCH33.33Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7702, the sentiment is Negative. The current price of 429.00 is below the 20-day moving average (MA) of 437.80, below the 50-day MA of 444.26, and below the 200-day MA of 434.41, indicating a bearish trend. The MACD of -5.00 indicates Positive momentum. The RSI at 44.15 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7702.

JMS Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:7702 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4543JP:454377OutperformJPY 3.71T22.8710.60%1.31%14.05%31.94%
JP:7747JP:774772OutperformJPY 1.02T31.5719.88%1.25%21.16%156.97%
JP:7733JP:773365NeutralJPY 1.95T21.1311.80%3.42%9.03%-2.99%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:7702JP:770252NeutralJPY 10.55B-14.93―3.96%-3.10%-645.01%
JP:8086JP:808648NeutralJPY 246.65B20.413.85%2.33%5.03%-0.86%

* General Sector Average

Performance Comparison

-25%0%25%50%75%JP:7702JP:4543JP:7747JP:8086JP:7733Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7702 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7702JMS Co., Ltd.429.004.401.04%
JP:4543Terumo2516.00166.407.08%
JP:7747Asahi Intecc Co 3807.001457.8262.06%
JP:8086Nipro Corporation1331.00-121.91-8.39%
JP:7733Olympus Corp1752.50-265.12-13.14%

JMS Co., Ltd. Corporate Events

JMS Posts Narrower Losses but Lower Sales in Q1 FY2026 While Maintaining Dividend Outlook

Aug 7, 2026

JMS Co., Ltd. reported consolidated net sales of ¥15,128 million for the first quarter ended June 2026, a 2.7% year-on-year decline, with operating and ordinary losses narrowing slightly compared with the prior year and profit attributable to owners...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 17, 2026